Author:
Hsieh Chee-Ruey,Liu Ya-Ming
Funder
National Science Council
Worldwide Health Economics Johnson and Johnson Pharmaceutical Services
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference14 articles.
1. Early development of therapeutic biologics—pharmacokinetics;Baumann;Curr Drug Metab,2006
2. The emerging role of pharmacogenomics in biologics;Lacanà;Clin Pharmacol Ther,2007
3. Characterizing markets for biopharmaceutical innovations: do biologics differ from small molecules?;Trusheim;Characterizing markets for biopharmaceutical innovations: do biologics differ from small molecules?,2010
4. Safety-related regulatory actions for biologicals approved in the United States and the European Union;Giezen;JAMA,2008
5. Market access for biopharmaceuticals: new challenges;Simon;Health Aff (Millwood),2006
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献